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Abstract
Purpose Although high costs are often cited as the main limitation of 3D printing (3DP) in the medical field, current lack of
clinical evidence is asserting itself as an impost as the field begins to mature. The aim is to review clinical trials in the field
of 3DP, an area of research which has grown dramatically in recent years.
Methods We surveyed clinical trials registered in 15 primary registries worldwide, including ClinicalTrials.gov. All trials
which utilized 3DP in a clinical setting were included in this review. Our search was performed on December 15, 2017.
Data regarding the purpose of the study, inclusion criteria, number of patients enrolled, primary outcomes, centers, start and
estimated completion dates were extracted.
Results A total of 92 clinical trials with N = 6252 patients matched the criteria and were included in the study. A total of
42 (45.65%) studies cited China as their location. Only 10 trials were multicenter and 2 were registered as international. The
discipline that most commonly utilized 3DP was Orthopedic Surgery, with 25 (27.17%) registered trials. At the time of data
extraction, 17 (18.48%) clinical trials were complete.
Conclusions After several years of case reports, feasibility studies and technical reports in the field, larger-scale studies are
beginning to emerge. There are almost no international register entries. Although there are new emerging areas of study in
disciplines that may benefit from 3DP, it is likely to remain limited to very specific applications.
Keywords 3D printing · Clinical trials · Anatomical models · Preoperative planning · Review
Introduction
Despite the presence of 3D printing (3DP) in medicine for
several years, many clinical centers have yet to adopt the
technology as part of routine clinical care, not merely due
to high costs and difficulties with segmentation—which are
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commonly known as the bottleneck of the process [1,2]—but
also due to lack of scientific evidence [3]. There remain insuf-
ficient studies reporting on the ways in which 3DP would
affect clinical decision-making and intervention outcomes.
Only a few randomized or even cohort and case-control stud-
ies are available, most of which are published in the fields
of Maxillofacial Surgery and Orthopedics [4]. Cardiology
emerges as another field with several valuable studies, both
in interventional [5] and educational [6] aspects. Currently,
clinical trials are being conducted to find new applications
of this technology in other medical fields.
There are several literature reviews published in the
medical 3DP space. They vary from general “reviews of
medical/surgical applications” [3,4,7] to case reports or even
conference abstracts, from specific fields such as: Neu-
rosurgery [8], Cardiology [9], Anesthesia [10] or Spinal
Surgery [11]. For example, our research group previously
published a systematic review on 3DP in liver surgery,
evaluating all 14 papers published in this specific area
[12]. Although certain fields such as Cardiothoracic Surgery
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Fig. 1 Main locations of 3DP clinical trials by country
already boast several reviews, there has yet to be a broader
evaluation of clinical trials in 3DP, which have increased dra-
matically in recent years.
The purpose of this article is to review all clinical trials
registered in international registries, including US National
Library of Medicine ClinicalTrials.gov database and the 15
databasesmerged in theWorldHealthOrganization’s (WHO)
International Clinical Trials Registry. To our knowledge, this
is the first review of clinical trials currently interrogating the
utility of 3DP.
Materials andmethods
Clinical trials registered in the ClinicalTrials.gov database,
EU Clinical Trials Register and—additionally—in World
Health Organization’s International Clinical Trials Registry
Platform were screened. The latter includes data from 15
primary registries worldwide, including Australia and New
Zealand’s ANZCTR, Chinese ChiCTR Registry, Japan’s
JPRN and more. Trials that utilized 3DP by any means were
included, without time, geographical or implementation lim-
itations.
The search was performed on December 15, 2017, using
the terms: “3Dprint*”, “additivemanufacturing”, “rapid pro-
totyping” and “bioprinting” (see Supplement 1 for full search
strategy). After removing duplicates and including only stud-
ies matching the inclusion criteria, we extracted data on:
purpose of the study, admission criteria, number of patients
enrolled, primary outcomes, centers (including the leading
and cooperating institutions and sponsors), start and esti-
mated completion date. Papers were segregated into different
fields based on their title, studied condition and description.
Results
Our database search yielded 132 results, from which 92
matched the inclusion criteria (N =6252 patients).
Worldwide distribution
3DP clinical trials were registered in 20 different countries
as main study locations (Fig. 1), most commonly in China
with 42 (45.65%) trials. The next most engaged locations
were USA and Egypt with 13 and 7 studies, respectively. All
Egypt’s studies were located at Cairo University.
Ten trials (10.87%) are registered as multicenter, but only
two (2.17%)have international collaboration:NCT02873403,
a 3DP knee-brace study based in Scotland with collaborators
in Germany, and NCT02846974 with main centre in Canada
and an external location within Al Shifa Hospital in Gaza.
Fields
By far, most common medical discipline that facilitates 3DP
is Orthopedics with 25 (27.17%) registered trials. Other
major fields are Dentistry and Maxillofacial Surgery with
13 (14.13%) and 10 (10.87%) trials, respectively (Table 1).
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Table 1 Registered clinical trials classified by field. All results are n
(%)
Field # of trials (n = 92)
Orthopedics 25 (27.17)
Dentistry 13 (14.13)
Maxillofacial surgery 10 (10.87)
ENT 7 (7.61)
Oncology 7 (7.61)
Ophthalmology 5 (5.43)
Cardiology/Cardiac surgery 4 (4.35)
Urology 4 (4.35)
Neurosurgery 4 (4.35)
General surgery 3 (3.26)
Others/Non-classified 10 (10.87)
Patient recruitment
At the time of data extraction, 43 (46.74%) trials were in the
process of enrolling patients in their studies. 17 (18.48%)
were already completed, 15 (16.3%) had yet to commence
recruiting patients, and 12 (13.04%)were still pending. There
were 4 (4.35%) studies with the “unknown” status and one
(1.09%) marked as active, but not recruiting.
Timeline and recruitment status
In our analysis, 89 (96.74%) studies were projected to com-
mence before 2018—32 (34.78%), of which in 2017, 30
(32.61%) in 2016 and 13 (14.13%) in 2015. 2 trials are
planned to commence in 2018. Most trials were projected
to finish in 2018, 2017 and 2019, with 22 (23.91%), 19 and
19 (20.65%) studies, respectively (Fig. 2).
Implementations
Due to large diversity of 3DP implementations in included
trials, it is not possible to perform any sort of statistical or
pooled analysis. We have described several examples of 3DP
applications in Table 2.
Discussion
This review, which surveys 92 registered clinical trials with a
projected enrollment of over 6000 patients, displays the rapid
growth of the field, its challenges, its current direction, and
how 3DP will be utilized by clinicians in the coming years.
There is a surge in number of trials registered after 2015,
especially in 2016 and 2017. This clearly displays the tran-
sition of 3DP from its early phases of end-users evaluating
its feasibility, to the next phase of serious implementation,
routine use and clinical trials.
The IDEAL framework divides innovations in surgery
and interventional procedures into five phases: (1) idea, (2)
development, (3) exploration, (4) assessment and (5) long-
term study [13,14]. As elucidated by our review, this process
clearly describes the current shifts in the field of clinical 3DP.
Prior to 2015, most clinicians were still postulating on the
future applications of 3DP, next steps and how it should be
applied. This correspondswith the “idea” and “development”
stages of the IDEAL framework [15–17]. The significant
number of publications and—as displayed in our review—
clinical trials, confirms the advance toward the “long-term
study” phase for the field.
This is especially important when considering the current
limitations stopping this technology from broader use. Typ-
ically, the barriers cited are those related to segmentation,
high costs and printing time [18]. The current lack of empiri-
cal evidence is another significant barrier toward the broader
adoption of the technology by more conservative clinicians.
As elucidated in our review,weproject that several dozen reg-
istered studies will publish their results in 2018–2020, which
will objectively demonstrate or rebut the feasibility and clin-
ical utility of 3DP. To date, these trials are largely limited to
only few fields: primarily Orthopedic Surgery, Maxillofacial
Surgery and Dentistry. Given the current state of the field,
this is unsurprising, but change may very well be afoot. A
systematic review by Martelli et al. from 2016 showed that
75% of all medical applications of 3DP are in the fields of
Orthopedics and Maxillofacial Surgery [3]. A similar pub-
lication by Tack et al.—inclusive of Dental publications—
displayed that greater than 50% of papers reside in these two
fields [4]. However, at the time of Tack’s study, only 4.82%
of papers were in the field of Dentistry, a percentage which
has increased significantly by the time of our review.
Dental clinical trials most often evaluate 3D-printed
complete (NCT03281603, NCT03354715, NCT03119753)
and partial (NCT01191073, NCT01191073, ChiCTR-ONC-
16009899, IRCT2015022221190N1) dentures. In Orthope-
dics and Maxillofacial Surgery, the use of 3DP implants is
of import. For instance, a large (300 patients) NCT03166917
trial will evaluate the clinical outcomes after using person-
alized 3DP implants to treat bone defects. With 3 centers
participating, this trial is one of the largest running and is pro-
jected to finish in 2021.Other implementations inOrthopedic
Surgery include orthoses (ChiCTR-OIC-17013130) and sur-
gical templates (ChiCTR-INR-16009961)
There are some very promising studies outside those
fields, i.e., in Cardiology andCardiac Surgery. In fact, French
study NCT03330210 (LAA-PrintRegis)—designed to start
in December 2017—will evaluate the outcomes of utilizing
3DP in left atrial appendage closure, enrolling 400 patients in
13 French institutions. ChiCTR-IPR-17012001, also includ-
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Fig. 2 Chart displaying number of trials starting and ending each year from 2005 to 2023
ing 400 subjects, aims to assess 3DP as adjunctive tool for
the diagnosis and treatment of right-sided congenital heart
malformations. Its projected completion date is 2020. These
trials would be a great addition to current state-of-the-art
literature in this field, which has already shown 3DP to be
beneficial for planning various interventions [19,20]. Even
fully personalized tools, including patient-specific occluders,
as described recently by Robinson et al., can be developed
[21] with additive manufacturing.
The clear role that 3DP can play in anatomical visu-
alization lends itself toward certain applications more so
than others, emphasized by the fact that multiple trials are
currently registered to treat specific conditions (i.e., eden-
tulous jaw, bone fractures, left atrial appendage occlusion,
aneurysms, congenital heart defects). On the other hand,
other disciplines may not be as suited to this technology,
where alternatives such as virtual or augmented reality may
be a better fit [22].
In conducting this review, we are aware of its limitations.
For instance, there exists clinical trials that are not regis-
tered in the databases we have surveyed in our methodology.
Nevertheless, the 92 studies we have compiled are suffi-
cient to provide commentary on the current state of the field.
In addition, some registered trials have “unknown” as their
database status andmaynot have been updated for some time.
Finally, this review cannot comment on how3DP affects clin-
ical decision-making, as we have yet to evaluate the results
of completed studies. A meta-analysis in the coming years
would be prudent to evaluate specific techniques, such as
left atrial appendage closure, where sufficient interventions
will have been completed to power statistical analysis. This
requires authors to publish substantiated, quantitative results,
which has been an issue in the past. Very often clinicians are
focused only on their opinions and qualitative results. Addi-
tionally, it might be obvious for some people that improved,
advanced three-dimensional visualizations offered by 3DP
are beneficial over traditional approach. Still, we will not be
able to implement the technology widely without analysis
of cost-effectiveness and facts about its impact on clinical
outcomes.
As active researchers in this field, it is exciting to see the
upswing in 3DP clinical trials being registered, as it is an
encouraging sign that the field is moving beyond its infancy.
After an initial period of gradual uptake of the technology
and gradual accumulation of evidence, we may soon witness
routine clinical implementation in a greater number of insti-
tutions, as its cost-effectiveness improves. The next pertinent
steps for medical 3DP going forward will be to build up a
larger body of empirical evidence.
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Table 2 Examples of implementations of 3DP in included clinical trials for various medical fields
Field Clinical trial registration # Implementation
Orthopedics NCT03185286 Personalized metal implants for bone defect surgeries
NCT02873403 3DP knee brace compared to conventional knee brace
NCT02845245 3DP prototype for preoperative planning in patients with distal
tibia fractures
Maxillofacial surgery NCT02914431 Personalized 3DP titanium plates vs. traditional surgical splints
in maxillary repositioning of orthognathic surgery
ChiCTR-ONC-17010475 3D CT-based bone model for reconstruction of
orbital-maxillary-zygomatic complex
ChiCTR-INR-16009695 Personalized, 3DP nasal bone positor for nasal bone fracture
treatment
Dentistry NCT03281603,
NCT03119753,
NCT03354715,
NCT01191073
3DP vs. conventional complete dentures
ENT NCT03111888 Patient-specific silicone stent airway implant for chronic
obstructive pulmonary disease patients
NCT02905344 3DP anatomical models to educate patients before deviated
nasal septum surgery
NCT02559050 Case of 3DP nasal stent for congenital arrhinia
Oncology NCT02952261 CT-based, 3DP device to localize small pulmonary nodule and
indicate puncture site
NCT02550210 Breast Cancer Locator—3DP bra-like form for intraoperative
guidance
Ophthalmology IRCT2017042633094N1 Personalized template for orbital floor fracture reconstruction
guidance
NCT01312545 3DP versus conventional orbital implant for enucleation
Cardiology and Cardiac surgery NCT03330210 Patient-specific left atrial appendage models for pre-procedural
device sizing and planning
ChiCTR-IPR-17012001 3D model and computer-based simulations versus traditional
imaging evaluation in planning treatment of right-sided
congenital heart disease
Urology ChiCTR-ONC-16010296 3DP extravascular stent placed laparoscopically in patients with
nutcracker syndrome
NCT03272529 Models for rehearsal of percutaneous nephrolithotomy
Neurosurgery ChiCTR-IOC-16009978 Simulation of intracranial aneurysm treatment
General surgery ISRCTN75603704 Patient-specific models for rectal cancer surgery rehearsal
Conclusions
This study displays the growing number of 3DP clinical trials
registered to international databases. Most are in the fields of
Orthopedics, Dentistry and Maxillofacial Surgery, but there
are emerging fields including ENT Surgery, Oncology and
Ophthalmology. The current paucity of international multi-
institutional trials highlights the current immaturity of the
field. Sixty registered trials are projected to be complete prior
to 2020, which would aid in the implementation of 3DP in
routine medical practice, should the outcomes support its
use. Despite this, implementation will likely only become
commonplace in medical disciplines where the benefits of
this technology will complement routine clinical practice.
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